GeoVax Labs Inc.

News & Events

Press Releases

In The Media

1. GeoVax to Report Third Quarter 2025 Financial Results and Provide Corporate Update on November 13, 2025

   NewMediaWire NOV 4, 2025 9:04 AM EST
   ATLANTA, GA - November 4, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-st...
   Read Article

2. GeoVax Announces Relocation of Corporate Headquarters and Laboratory Operations to Support Accelerated Growth and Pipeline Advancement

   NewMediaWire NOV 3, 2025 9:04 AM EST
   Relocations Strengthen Ties to Georgia’s Bio-Ecosystem and Position GeoVax for Late-Stage ...
   Read Article

3. BIO CEO Warns U.S. Could Lose Biotech Leadership Within Two Years; GeoVax Calls on Congress and Administration to Act Now

   NewMediaWire OCT 30, 2025 1:03 PM EDT
   Following John Crowley’s Testimony, GeoVax Highlights Urgent Need for Vaccine Platform Div...
   Read Article

4. GeoVax Connects IDSA Guidance on COVID-19 Vaccination for Immunocompromised Patients With Recent Clinical Data for GEO-CM04S1

   NewMediaWire OCT 29, 2025 9:06 AM EDT
   IDSA’s Recommendations Reinforce GeoVax’s Phase 2 Findings: Robust T-Cell Responses...
   Read Article

5. GeoVax Welcomes New IDSA Guidance Highlighting Need for Tailored COVID-19 Vaccines for Immunocompromised Patients

   NewMediaWire OCT 28, 2025 9:03 AM EDT
   GEO-CM04S1 Designed to Deliver Broader, More Durable Protection for the 40 Million Americans Left...
   Read Article

6. GeoVax Highlights Urgent Need for Multisource Mpox Vaccine Supply Following California Clade 1 Cases

   NewMediaWire OCT 20, 2025 10:33 AM EDT
   EMA Endorses Expedited Development Pathway for GEO-MVA; Company Advances U.S.-Based Continuous Ce...
   Read Article

7. GeoVax Highlights Positive Interim Results for Multi-Antigen COVID-19 Vaccine in Immunocompromised Patients at World Vaccine Congress Europe 2025

   NewMediaWire OCT 16, 2025 9:04 AM EDT
   Presentations Underscore Favorable Safety Profile and Robust T-Cell Responses of GEO-CM04S1 in Vu...
   Read Article

8. GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions

   NewMediaWire OCT 13, 2025 9:03 AM EDT
   Executives to Participate at World Vaccine Congress Europe (Amsterdam, Oct 13–16) and BIO-...
   Read Article

9. GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025

   NewMediaWire OCT 9, 2025 9:03 AM EDT
   Presentations to Highlight Interim Safety Data and Special-Populations Insights for GEO-CM04S1 in...
   Read Article

10. GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

    NewMediaWire OCT 7, 2025 9:04 AM EDT
    David Dodd, Chairman & CEO, A vailable for I nvestor M eetings ATLAN...
    Read Article